The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]
  • No CSPEC related information was provided by the message!

  • See Evidence submitted by expert panel for details.

Variant: NM_000527.5(LDLR):c.2140+5G>A

CA023645

36460 (ClinVar)

Gene: LDLR
Condition: hypercholesterolemia, familial
Inheritance Mode: Semidominant inheritance
UUID: 56e1a7d8-b14a-4759-be2e-3a9ea6668dec
Approved on: 2021-06-18
Published on: 2021-06-24

HGVS expressions

NM_000527.5:c.2140+5G>A
NM_000527.5(LDLR):c.2140+5G>A
NC_000019.10:g.11120527G>A
CM000681.2:g.11120527G>A
NC_000019.9:g.11231203G>A
CM000681.1:g.11231203G>A
NC_000019.8:g.11092203G>A
NG_009060.1:g.36147G>A
ENST00000558518.6:c.2140+5G>A
ENST00000252444.9:n.2394+5G>A
ENST00000455727.6:c.1636+5G>A
ENST00000535915.5:c.2017+5G>A
ENST00000545707.5:c.1606+294G>A
ENST00000557933.5:c.2140+5G>A
ENST00000558013.5:c.2140+5G>A
ENST00000558518.5:c.2140+5G>A
NM_000527.4:c.2140+5G>A
NM_001195798.1:c.2140+5G>A
NM_001195799.1:c.2017+5G>A
NM_001195800.1:c.1636+5G>A
NM_001195803.1:c.1606+294G>A
NM_001195798.2:c.2140+5G>A
NM_001195799.2:c.2017+5G>A
NM_001195800.2:c.1636+5G>A
NM_001195803.2:c.1606+294G>A
More

Benign

Met criteria codes 2
BS3_Supporting BA1
Not Met criteria codes 24
BS2 BS1 BS4 BP5 BP7 BP3 BP1 BP2 BP4 PS1 PS2 PS3 PS4 PP1 PP2 PP3 PP4 PM1 PM3 PM5 PM4 PVS1 PM6 PM2

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specifications for this VCEP
Evidence submitted by expert panel
Familial Hypercholesterolemia VCEP
NM_000527.5(LDLR):c.2140+5G>A variant is classified as Benign for Familial Hypercholesterolemia by applying evidence codes (BA1, BS3_Supporting) as defined by the ClinGen Familial Hypercholesterolemia Expert Panel LDLR-specific variant curation guidelines (https://doi.org/10.1101/2021.03.17.21252755). The supporting evidence is as follows: BA1 - FAF = 0.01030 (1.030%) in European non-Finnish exomes (gnomAD v2.1.1). BS3_supporting - Level 3 assay: PMID:19208450 - study on patient's lymphocytes, Northern blot + real-time PCR + FACS used: normal mRNA processing + 108% low-density lipoprotein receptor activity. ---- functional study is consistent with no damaging effect.
Met criteria codes
BS3_Supporting
Level 3 assay: PMID:19208450 - study on patient's lymphocytes, Northern blot + real-time PCR + FACS used: normal mRNA processing + 108% low-density lipoprotein receptor activity. ---- functional study is consistent with no damaging effect.
BA1
FAF = 0.01030 (1.030%) in European non-Finnish exomes (gnomAD v2.1.1). FAF is above 0.5%
Not Met criteria codes
BS2
Most of labs do not track clinical data in this variant due to classifying as benign in the past.
BS1
BA1 is met. Not applicable.
BS4
Most of labs do not track clinical data in this variant due to classifying as benign in the past.
BP5
Not applicable.
BP7
Intronic variant. Not applicable.
BP3
Not applicable.
BP1
Not applicable.
BP2
Most of labs do not track clinical data in this variant due to classifying as benign in the past.
BP4
Functional data available. Not applicable.
PS1
Intronic variant. Not applicable.
PS2
No de novo cases were identified.
PS3
No well established in vitro or in vivo functional studies supportive of a damaging effect on the gene or gene product.
PS4
PM2 is not met. Not applicable.
PP1
Most of labs do not track clinical data in this variant due to classifying as benign in the past.
PP2
Not applicable.
PP3
Functional data available. Not applicable.
PP4
PM2 is not met. Not applicable.
PM1
Intronic variant. Not applicable.
PM3
Most of labs do not track clinical data in this variant due to classifying as benign in the past.
PM5
Intronic variant. Not applicable.
PM4
Intronic variant. Not applicable.
PVS1
Intronic variant outside the canonical +/- 1 or 2 splice sites. Not applicable.
PM6
No de novo cases were identified.
PM2
PopMax MAF = 0.03088 (3.1%) in Ashkenazi Jewish exomes (gnomAD v2.1.1). FAF is not below 0.02%.
Curation History
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
¤ Powered by BCM's Genboree.